Article Listing - Par Pharmaceutical Begins Shipment of Generic Atacand HCT

OPTIMIZATION OF GLOBAL R&D STRATEGY

20 April 1992

Because pharmaceutical development times contain, of necessity, prescribed periods which are of similar duration for competing innovator companies (eg long-term...

MERGER DENIALS BY CIBA-GEIGY

20 April 1992

Alex Krauer, managing director of the Swiss chemical and pharmaceutical concern, Ciba-Geigy, has denied that his company could be about...

US FDA USER FEE REG THIS MONTH?

20 April 1992

User fee legislation is currently being drafted by the US Food and Drug Administration and could be ready for submission...

US AIDS MARKET FORECASTS TO 1998

20 April 1992

The US market for products to diagnose, monitor and treat AIDS will grow from close to $300 million in 1991...

STREP PNEUMONIAE VACCINE IN DEV'T

20 April 1992

A new improved vaccine directed against the bacterium responsible for bacterial meningitis and various other infectious diseases, Streptococcus pneumoniae ,...

DRUG REVIEW PLAN SETS FOUR INITIATIVES

20 April 1992

Four initiatives are to be implemented by the US Food and Drug Administration to speed access to new drugs and...

JOHN PETRICCIANI JOINS GENETICS INSTITUTE

20 April 1992

John Petricciani, previously vice president for medical and regulatory affairs as the US Pharmaceutical Manufacturers Association, has moved to Genetics...

CELTRIX' THOMAS DAVIS

20 April 1992

Thomas Davis is elected to the board of directors at Celtrix Pharmaceuticals.

CANGENE CANCER DRUG IN TRIALS?

20 April 1992

Canadian biotechnology concern Cangene has applied for permission from the Canadian government to begin clinical testing of leucotropin, the company's...

CHINESE ARTHRITIS REMEDY UNDER TEST

20 April 1992

Researchers at the University of Texas Southwestern Medical Center in the USA have applied to the US Food and Drug...

Showing 94281-94290 of 95376 articles

Go to beginningPreviousNextGo to end